SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase IIb, international, multicentre, double-blind, randomised,
placebo-controlled study is to determine the effect of hydroxycarbamide on albuminuria after
6 months of treatment in SCD adult patients.